18F-Fluorocholine for the Detection of Parathyroid Adenomas
Summary
- Eligibility
- for people ages 13 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Thomas Hope
Description
Summary
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Thomas Hope
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center. He also serves as chair of the the Cancer Center’s Molecular Imaging & Radionuclide Therapy Site Committee.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT03764007
- Phase
- Phase 2/3
- Study Type
- Interventional
- Last Updated